Ceros Capital Markets

GT Metabolic Solutions develops a minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery.

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions for potential cancer in seconds.

Pristine Surgical has developed a first-of-its-kind, single-use visualization platform for surgical and diagnostic rigid endoscopic procedures by combining state-of-the-art, high-definition digital imaging with advanced LED lighting, artificial intelligence and cloud-based software. Its single-use arthroscopes and laparoscopes are delivered in a 100% sterile kit, and together with its cloud-based workflow reduction software, promises to reduce cost, reduce risk and increase efficiency for over 23 million procedures per year.

Pathology Watch delivers an intuitive and easy-to-implement digital pathology solution for dermatologists. They work with clinical dermatology practices to digitize the pathology workflow, which is helping to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. They also deliver an intuitive and easy-to-implement digital pathology solution that includes access to top-tier Dermatopathologists. It was founded in 2017 and is based in Salt Lake City, Utah.